---
schema_version: "secwatch.filing_event.v1"
accession: "0001567264-26-000049"
form_type: "8-K"
ticker: "INTS"
cik: "0001567264"
company_name: "INTENSITY THERAPEUTICS, INC."
filed_at: "2026-06-16T20:15:07+00:00"
generated_at: "2026-06-16T20:16:13.447669+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Intensity Therapeutics stockholders elect directors, approve equity plan amendments at annual meeting

## Summary
- Elected Dr. Emer Leahy and Lewis H. Bender as Class III directors with ~416,613 and ~422,149 votes for, respectively.
- Ratified EisnerAmper LLP as auditor for FY 2026 with 1,024,971 votes for, 4,852 against.
- Approved amendment to 2021 Stock Incentive Plan to increase shares by 150,000 (363,563 for, 69,252 against).
- Approved amendment to 2024 ESPP to increase shares by 25,000 (407,404 for, 25,350 against).
- Adjournment proposal passed with 939,304 votes for, 126,814 against.

## SEC filing metadata
- accession: 0001567264-26-000049
- form_type: 8-K
- ticker: INTS
- cik: 0001567264
- company_name: INTENSITY THERAPEUTICS, INC.
- filed_at: 2026-06-16T20:15:07+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1567264/000156726426000049/0001567264-26-000049-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1567264/000156726426000049/intensity-20260616.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001567264-26-000049
- JSON: https://secwatch.observer/filing/0001567264-26-000049.json
- Plain text: https://secwatch.observer/filing/0001567264-26-000049.txt

## Key facts
- Shareholder Votes
  INTENSITY THERAPEUTICS, INC. shareholders approved Approval of amendment to 2024 Employee Stock Purchase Plan to increase shares available by 25,000 at the 2026-06-16 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2026-06-16
  source text: For Against Abstain Broker Non-Votes 407,404 25,350 3,324 643,416
  evidence_url: https://www.sec.gov/Archives/edgar/data/1567264/000156726426000049/0001567264-26-000049-index.htm
- Shareholder Votes
  INTENSITY THERAPEUTICS, INC. shareholders approved Ratification of selection of EisnerAmper LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-16 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-16
  source text: For Against Abstain 1,024,971 4,852 49,671
  evidence_url: https://www.sec.gov/Archives/edgar/data/1567264/000156726426000049/0001567264-26-000049-index.htm
- Shareholder Votes
  INTENSITY THERAPEUTICS, INC. shareholders approved Approval of any postponement or adjournment of 2026 annual meeting, if necessary at the 2026-06-16 meeting.
  - Outcome: passed
  - Meeting: 2026-06-16
  source text: For Against Abstain 939,304 126,814 13,376
  evidence_url: https://www.sec.gov/Archives/edgar/data/1567264/000156726426000049/0001567264-26-000049-index.htm
- Shareholder Votes
  INTENSITY THERAPEUTICS, INC. shareholders approved Election of two Class III directors to hold office until the 2029 annual meeting at the 2026-06-16 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-16
  source text: Nominee For Withheld Broker Non-Votes Dr. Emer Leahy 416,613 19,465 643,416 Lewis H. Bender 422,149 13,929 643,416
  evidence_url: https://www.sec.gov/Archives/edgar/data/1567264/000156726426000049/0001567264-26-000049-index.htm
- Shareholder Votes
  INTENSITY THERAPEUTICS, INC. shareholders approved Approval of amendment to 2021 Stock Incentive Plan to increase shares available by 150,000 at the 2026-06-16 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2026-06-16
  source text: For Against Abstain Broker Non-Votes 363,563 69,252 3,263 643,416
  evidence_url: https://www.sec.gov/Archives/edgar/data/1567264/000156726426000049/0001567264-26-000049-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.